‘LIfe-Changing’ Psychedelic, for When Life Is Ending
Posted inAnxiety and Stress Cancer Cancer (Journal) Death and Dying Depression (Mental) Drugs (Pharmaceuticals) Food and Drug Administration Hospice Care Journal of Psychopharmacology Ketamine (Drug) Oregon Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychiatry and Psychiatrists Regulation and Deregulation of Industry Research Veterans Veterans Affairs Department

‘LIfe-Changing’ Psychedelic, for When Life Is Ending

People are turning to psilocybin, ketamine and other treatments for palliative care.
Veterans Dept. Investigating Acadia Healthcare for Insurance Fraud
Posted inAcadia Healthcare Company Inc Health Insurance and Managed Care Hospitals Inspectors General Regulation and Deregulation of Industry Securities and Commodities Violations Veterans Veterans Affairs Department your-feed-healthcare

Veterans Dept. Investigating Acadia Healthcare for Insurance Fraud

Several federal agencies are investigating whether the large chain of psychiatric hospitals held patients without medical justification.
F.D.A. Declines to Approve MDMA Therapy, Seeking More Study
Posted inClinical Trials Drug Enforcement Administration Drugs (Pharmaceuticals) Ecstasy (Drug) Food and Drug Administration LSD (Lysergic Acid Diethylamide) Lykos Therapeutics Mental Health and Disorders Post-Traumatic Stress Disorder Psilocybin Mushrooms Psychedelic and Hallucinogenic Drugs Psychology and Psychologists Regulation and Deregulation of Industry Research Therapy and Rehabilitation Veterans

F.D.A. Declines to Approve MDMA Therapy, Seeking More Study

The agency said there was insufficient data to allow the use of a treatment for PTSD that involves the drug known as Ecstasy, according to the company seeking approval.